These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
3. Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer. Wen S; Niu Y; Huang H Asian J Urol; 2020 Jul; 7(3):203-218. PubMed ID: 33024699 [TBL] [Abstract][Full Text] [Related]
4. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Savoy RM; Chen L; Siddiqui S; Melgoza FU; Durbin-Johnson B; Drake C; Jathal MK; Bose S; Steele TM; Mooso BA; D'Abronzo LS; Fry WH; Carraway KL; Mudryj M; Ghosh PM Endocr Relat Cancer; 2015 Jun; 22(3):369-86. PubMed ID: 25759396 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
6. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor cofactors in prostate cancer: potential therapeutic targets of castration-resistant prostate cancer. Shiota M; Yokomizo A; Fujimoto N; Naito S Curr Cancer Drug Targets; 2011 Sep; 11(7):870-81. PubMed ID: 21762076 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer. Cai Z; Chen W; Zhang J; Li H Int Urol Nephrol; 2018 Oct; 50(10):1753-1764. PubMed ID: 30128923 [TBL] [Abstract][Full Text] [Related]
9. Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors. Connelly ZM; Yang S; Chen F; Yeh Y; Khater N; Jin R; Matusik R; Yu X Am J Clin Exp Urol; 2018; 6(5):172-181. PubMed ID: 30510969 [TBL] [Abstract][Full Text] [Related]
10. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Metzler VM; de Brot S; Haigh DB; Woodcock CL; Lothion-Roy J; Harris AE; Nilsson EM; Ntekim A; Persson JL; Robinson BD; Khani F; Laursen KB; Gudas LJ; Toss MS; Madhusudan S; Rakha E; Heery DM; Rutland CS; Mongan NP; Jeyapalan JN Front Cell Dev Biol; 2023; 11():1116424. PubMed ID: 37152294 [TBL] [Abstract][Full Text] [Related]
11. Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer. Khurana N; Sikka SC Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027362 [TBL] [Abstract][Full Text] [Related]
12. The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors. Xie N; Cheng H; Lin D; Liu L; Yang O; Jia L; Fazli L; Gleave ME; Wang Y; Rennie P; Dong X Int J Cancer; 2015 Feb; 136(4):E27-38. PubMed ID: 25138562 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer. Singh VK; Kainat KM; Sharma PK Vitam Horm; 2023; 122():253-282. PubMed ID: 36863797 [TBL] [Abstract][Full Text] [Related]
14. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression. Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770 [TBL] [Abstract][Full Text] [Related]
15. Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Kleb B; Estécio MR; Zhang J; Tzelepi V; Chung W; Jelinek J; Navone NM; Tahir S; Marquez VE; Issa JP; Maity S; Aparicio A Epigenetics; 2016 Mar; 11(3):184-93. PubMed ID: 26890396 [TBL] [Abstract][Full Text] [Related]
16. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168 [TBL] [Abstract][Full Text] [Related]
17. Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. Deng T; Xiao Y; Dai Y; Xie L; Li X Front Mol Biosci; 2021; 8():743376. PubMed ID: 34977151 [TBL] [Abstract][Full Text] [Related]
18. Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer. Han W; Gao S; Barrett D; Ahmed M; Han D; Macoska JA; He HH; Cai C Oncogene; 2018 Feb; 37(6):710-721. PubMed ID: 29059155 [TBL] [Abstract][Full Text] [Related]
19. YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth. Jiang N; Ke B; Hjort-Jensen K; Iglesias-Gato D; Wang Z; Chang P; Zhao Y; Niu X; Wu T; Peng B; Jiang M; Li X; Shang Z; Wang Q; Chang C; Flores-Morales A; Niu Y Oncotarget; 2017 Dec; 8(70):115054-115067. PubMed ID: 29383141 [TBL] [Abstract][Full Text] [Related]
20. Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cucchiara V; Yang JC; Mirone V; Gao AC; Rosenfeld MG; Evans CP Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28275218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]